RESUMEN
In the present study, the cells of Bifidobacterium animalis subsp. lactis (BI-01) and Lactobacillus acidophilus (LAC-04) were encapsulated in cocoa butter using spray-chilling technology. Survival assays were conducted to evaluate the resistance of the probiotics to the spray-chilling process, their resistance to the simulated gastric and intestinal fluids (SGF and SIF), and their stability during 90 days of storage. The viability of the cells was not affected by microencapsulation. The free and encapsulated cells of B. animalis subsp. lactis were resistant to both SGF and SIF. The micro-encapsulated cells of L. acidophilus were more resistant to SGF and SIF than the free cells; the viability of the encapsulated cells was enhanced by 67%, while the free cells reached the detection limit of the method (10³ CFU/g). The encapsulated probiotics were unstable when they were stored at 20 °C. The population of encapsulated L. acidophilus decreased drastically when they were stored at 7 °C; only 20% of cells were viable after 90 days of storage. The percentage of viable cells of the encapsulated B. animalis subsp.lactis, however, was 72% after the same period of storage. Promising results were obtained when the microparticles were stored at -18 °C; the freeze granted 90 days of shelf life to the encapsulated cells. These results suggest that the spray-chilling process using cocoa butter as carrier protects L. acidophilus from gastrointestinal fluids. However, the viability of the cells during storage must be improved.
Asunto(s)
Bifidobacterium/fisiología , Biotecnología/métodos , Composición de Medicamentos/métodos , Lactobacillus acidophilus/fisiología , Viabilidad Microbiana/efectos de los fármacos , Viabilidad Microbiana/efectos de la radiación , Probióticos/farmacología , Aerosoles , Estabilidad de Medicamentos , Grasas de la Dieta/metabolismo , Temperatura , Tecnología Farmacéutica/métodosRESUMEN
In the present study, the cells of Bifidobacterium animalis subsp. lactis (BI-01) and Lactobacillus acidophilus (LAC-04) were encapsulated in cocoa butter using spray-chilling technology. Survival assays were conducted to evaluate the resistance of the probiotics to the spray-chilling process, their resistance to the simulated gastric and intestinal fluids (SGF and SIF), and their stability during 90 days of storage. The viability of the cells was not affected by microencapsulation. The free and encapsulated cells of B. animalis subsp. lactis were resistant to both SGF and SIF. The micro-encapsulated cells of L. acidophilus were more resistant to SGF and SIF than the free cells; the viability of the encapsulated cells was enhanced by 67%, while the free cells reached the detection limit of the method (10(3) CFU/g). The encapsulated probiotics were unstable when they were stored at 20 °C. The population of encapsulated L. acidophilus decreased drastically when they were stored at 7 °C; only 20% of cells were viable after 90 days of storage. The percentage of viable cells of the encapsulated B. animalis subsp.lactis, however, was 72% after the same period of storage. Promising results were obtained when the microparticles were stored at -18 °C; the freeze granted 90 days of shelf life to the encapsulated cells. These results suggest that the spray-chilling process using cocoa butter as carrier protects L. acidophilus from gastrointestinal fluids. However, the viability of the cells during storage must be improved.
Asunto(s)
Bifidobacterium/fisiología , Biotecnología/métodos , Composición de Medicamentos/métodos , Lactobacillus acidophilus/fisiología , Viabilidad Microbiana/efectos de los fármacos , Viabilidad Microbiana/efectos de la radiación , Probióticos/farmacología , Aerosoles , Grasas de la Dieta/metabolismo , Estabilidad de Medicamentos , Tecnología Farmacéutica/métodos , TemperaturaRESUMEN
1. The present study provides an analysis of the interpretation and usefulness of mass biochemical urine screening tests currently applied to a population of severely ill children consisting of 232 unselected individuals, under various medications, held in intensive care units. 2. Testing for glycosaminoglycans by the cetyltrimethylammonium bromide reaction is of little benefit to this population. The Ehrlich reaction, used to detect porphobilinogen, should be reserved for cases which present clinical symptoms. Owing to the large number of false-positives and because chromatography or electrophoresis can easily be used to detect tyrosine, it is suggested that the nitrosonaphthol test be abandoned. The cyanide nitroprusside reaction should be used when chromatography or electrophoresis suggests cystinuria, homocystinuria or beta-mercapto lactate disulfiduria. 3. Because of its high sensitivity in detecting reducing substances, the Clinitest is useful for selecting samples to be investigated further by sugar chromatography. 4. Given the relatively high frequency of organic acidurias, particularly methylmalonic aciduria, in intensive care unit populations, it is suggested that the p-nitroaniline reaction be incorporated into the battery of chemical urine tests. 5. A comparison between paper chromatography and high voltage paper electrophoresis in terms of effective analysis of amino acid patterns demonstrated that chromatography is preferential, since this is as sensitive as electrophoresis, does not require a special apparatus and permits the simultaneous use of plasma and urine from the same patient, thus facilitating the interpretation of amino acid patterns.